Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Mar;32(1):17-31.
doi: 10.1007/s00281-009-0188-x. Epub 2010 Feb 2.

Biology of interleukin-22

Affiliations
Review

Biology of interleukin-22

Kerstin Wolk et al. Semin Immunopathol. 2010 Mar.

Abstract

Interleukin (IL)-22 is a member of the IL-10 family of cytokines and represents an important effector molecule of activated Th22, Th1, and Th17 cells, as well as Tc-cell subsets, gammadelta T cells, natural killer (NK), and NKT cells. IL-22 mediates its effects via a heterodimeric transmembrane receptor complex consisting of IL-22R1 and IL-10R2 and subsequent Janus kinase-signal transducers and activators of transcription (JAK-STAT) signaling pathways including Jak1, Tyk2, and STAT3. Whereas in some aspects, IL-22 acts synergistically with tumor necrosis factor-alpha, IL-1beta, or IL-17, most functions of IL-22 are unique. Importantly, IL-22 does not serve the communication between immune cells. It mainly acts on epithelial cells and hepatocytes, where it favors the antimicrobial defense, regeneration, and protection against damage and induces acute phase reactants and some chemokines. This chapter illuminates in detail the properties of IL-22 with respect to its gene, protein structure, cellular sources, receptors, target cells, biological effects, and, finally, its role in chronic inflammatory diseases, tumors, and infection.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Clin Invest. 2008 Feb;118(2):534-44 - PubMed
    1. FEBS Lett. 2008 Sep 3;582(20):2985-92 - PubMed
    1. Immunity. 2009 Aug 21;31(2):321-30 - PubMed
    1. J Clin Invest. 2008 Feb;118(2):597-607 - PubMed
    1. J Exp Med. 2009 Feb 16;206(2):299-311 - PubMed

LinkOut - more resources